70 likes | 80 Views
Antithrombin works by inhibiting certain enzymes involved in the blood clotting process, particularly thrombin (factor IIa) and activated factor X. These enzymes are essential for the formation of fibrin, a protein that forms the meshwork of a blood clot. By inhibiting thrombin and factor Xa, antithrombin helps regulate the clotting cascade and prevent the formation of excessive blood clots.
E N D
Antithrombin Market
Segmentation (Scope) By Application By Source & Dosage Form • Therapeutics • Human • Goat Milk • Research • Others • Diagnostics • Lyophilized • Others • Liquid © Coherent Market Insights. All Rights Reserved
Major Drivers • Surgery and Trauma: Surgical procedures and traumatic injuries can trigger a cascade of events that promote blood clotting. • Cancer and Chemotherapy: Cancer itself, as well as certain types of chemotherapy, can increase the risk of abnormal blood clotting. © Coherent Market Insights. All Rights Reserved
NORTH AMERICA ASIA PACIFIC Market Size US$ 577.4 million Market Size US$ 849.87 million CAGR 4.3%. CAGR 4.6%. © Coherent Market Insights. All Rights Reserved
Major Players Grifols Shire BDI Pharma rEVO Biologics Green Cross Corp CSL Limited GTC Biotherapeutics KedrionS.p.A Scripps Laboratories Inc. Lee Bisolutions © Coherent Market Insights. All Rights Reserved
Global Latex Medical Disposables Market (%)Analysis, By Product Type, 2023 30% ? ? ? ? Recombinant Antithrombin Plasma-derived Antithrombin Synthetic Antithrombin Others © Coherent Market Insights. All Rights Reserved